Bharat Biotech in-licences GSK's Shigella vaccine candidate |...

Dununu.com Dununu

Sponsorluk

Bharat Biotech in-licences GSK's Shigella vaccine candidate

RSS Feed Business

Posted

54

Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.

Read Full Article

Please log in to like, share and comment!

'Wedding of liberal royalty': Alex Soros marries Hillary Clinton's ex-aide Huma Abedin

By 0 0

Aamir on reason behind naming his children Junaid, Ira, Azad

Aamir Khan recently addressed the reason behind his children's Islamic-rooted names, Junaid, Ira,...

By 0 1

Trade Tower Limited IPO allotment finalized

KATHMANDU: The IPO allotment of Trade Tower Limited was completed in Kathmandu today. From Jestha...

By 0 4

Landing gear snag: Air India Delhi-Vadodara flight makes emergency landing

By 0 5

'It's okay': Yuvraj takes a cheeky dig at Australia as SA win WTC title

Yuvraj Singh celebrated South Africa's historic World Test Championship victory over Australia at...

By 0 9